← FDA Drug Approvals (Drugs@FDA)

ELTROMBOPAG OLAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2026-01-14

Drug application

FDA Application #

ANDA220250

Application type

Abbreviated New Drug Application (Generic)

Brand name

ELTROMBOPAG OLAMINE

Generic name

ELTROMBOPAG OLAMINE

Active ingredients

ELTROMBOPAG OLAMINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2026-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown